Clinical trial
The Safety and Efficacy of Autologous Probiotics in Patients With Defunctioning Ileostomy Following Low Anterior Resection for Rectal Cancer.
NCT07366047 is registered in ClinicalTrials.gov with Peking University Cancer Hospital & Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Safety and Efficacy of Autologous Probiotics in Patients With Defunctioning Ileostomy Following Low Anterior Resection for Rectal Cancer.
- Lead sponsor
- Peking University Cancer Hospital & Institute
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- December 31, 2025
- Completion date
- December 31, 2027
- Enrollment
- 40 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
autologous probiotic transplantation, defunctioning ileostomy, gut microbiomes, rectal cancer